Abstract B023: Identifying therapeutic vulnerabilities in metastatic prostate cancer transcriptional phenotypesDavid A. Gallo, Marina N. Sharifi, Emily Abella et al.|Cancer Research|2026Cited by 0
Abstract A030: Lossless altered histone modification analysis system to investigate patient derived cancer organoids and circulating tumor cells from patients with prostate cancerZachary J. Kauffman, Joshua M. Lang, Kevin Koesser et al.|Cancer Research|2026Cited by 0
Abstract B073: Circulating Tumor Cell (CTC) single cell protein quantification reveals inter-patient heterogeneity in PSMA expression associated with LuPSMA response in a Metastatic Castration Resistant Prostate Cancer (mCRPC) patient cohortWilliam M. Stump, Marina N. Sharifi, Alex H. Chang et al.|Cancer Research|2026Cited by 0